Medicare issues local coverage determination for biocept's target selector™ breast cancer assay to detect the her2 biomarker from circulating tumor cells

San diego--(business wire)-- #breastcancer--biocept receives medicare coverage for breast cancer assay to detect and analyze her2 biomarker and announces cnside and covid-19 testing updates.

BIOC Ratings Summary

BIOC Quant Ranking